Researchers at the University of Bath have identified a growing public health concern involving the use of spice-laced vaping devices among children in the United Kingdom. A study analyzing 1,923 vapes confiscated from young people across 114 English schools found that 13% contained spice, with higher concentrations in certain regions—25% in London and Lancashire. Among vapes specifically labeled as containing THC, CBD, or cannabis, a drug-testing service found that 39% of 297 samples actually contained spice instead.
Spice refers to a broad category of synthetic cannabinoids, with over 250 chemical variations identified. Unlike natural cannabis, which partially binds to certain cell receptors, spice binds much more strongly and produces significantly more potent effects. According to researchers, spice carries substantial health risks including acute psychiatric symptoms, aggressive behavior, elevated blood pressure, seizures, and cardiac arrest. A 2015 Global Drugs Survey indicated that the risk of requiring emergency medical care when using spice was 30 times greater than with cannabis.
These products are being marketed and sold primarily through social media platforms, particularly TikTok. An analysis estimated that approximately 68% of vapes purchased through TikTok contained spice, compared with 12% purchased via Facebook. Young people are often misled into believing they are purchasing legitimate THC vapes at low prices, sometimes for as little as ten pounds. The lack of distinguishing odor in spice vapes makes detection difficult in school and home settings, contributing to undetected usage.
The economic incentive for dealers is substantial. Manufacturing costs for spice are minimal—approximately £1,000 to £1,500 can produce a kilogram—yet the same quantity sold as vape liquid can generate roughly £1 million in revenue. Health and social care professionals report that spice is highly addictive, placing vulnerable young people at increased risk of criminal involvement and exploitation by drug dealers.
Regulatory efforts have faced challenges. Under the Online Safety Act, technology companies are required to remove drug-related content from their platforms, yet enforcement remains inconsistent. Researchers have presented evidence to policymakers and regulatory bodies, including Ofcom, advocating for stronger enforcement measures and penalties against social media firms that fail to meet their legal obligations. However, progress on implementing stricter action has been slow despite documented public health risks to vulnerable populations.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI